Mar 25, 2022 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Valeo Pharma Inc. first-quarter results conference call. (Operator Instructions) This call is being recorded Friday, March 25, 2022. I would now like to turn the conference over to Mr. Frederic Dumais, Director of Communications and Investor Relations. Please go ahead.
Frederic Dumais - Valeo Pharma Inc. - Director of Communications & IR
Thank you, operator. Good morning, everyone. Present with me today on the call are Mr. Steve Saviuk, our CEO; Mr. Frederic Fasano, our President and Chief Operating Officer; and Mr. Luc Mainville, our Senior VP and Chief Financial Officer.
Before we begin with our first-quarter 2022 results conference call, I would like to remind everyone that this conference call may contain certain forward-looking statements regarding the company's expectations or future events. Such expectations are based on certain assumptions that are founded on currently available information.
If these assumptions prove incorrect, actual results may differ materially from those
Q1 2022 Valeo Pharma Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot